Better, faster and more accessible healthcare, enabling world-class leadership teams to succeed on the global stage.
Close

Biocare Medical

Biocare Medical is a leading developer of oncology focused immunohistochemistry (IHC) and in situ hybridisation (ISH) reagents for diagnosis and chromosomal profiling alongside an array of diagnostics instruments.
Visit Website Read more
Invested
December 2021
Status
Current
Subsector
MedTech, PharmaBio
Corporate HQ
California, US

Biocare Medical is a leading developer of oncology focused immunohistochemistry (IHC) and in situ hybridisation (ISH) reagents for diagnosis and hromosomal profiling alongside an array of diagnostics instruments.

The Biocare portfolio of high-quality antibodies provides increased confidence for laboratory processes and critical diagnostics for patient therapies. The company’s core customers focus on clinical laboratories, bio-pharmaceutical companies and CRO’s.

Enablement & Alignment

Opportunity to create a global industry leader in IHC and ISH, servicing clinical labs and innovators in Pharma and Biotech.

Capability & Capacity

Enhanced investment and continued focus on product research and development as the business continues to target attractive adjacencies.

Development of further instrument lines driving significant market evolution to target underserved markets.

Building Strategic Footprints

Execution of organic and inorganic geographic expansion, in support of increasing global customer demand.

Biocare News